Please see publication from the AIHW on summary of key points in AIHW's 'Alcohol and other drug treatment services in Australia: early insights'. You can find more information here.

Summary of Key Points

In 2022-23

• Around 131,500 people received publicly funded treatment or support for alcohol and other drug (AOD) use.
• A total of 235,461 treatment episodes were provided to people for their own or someone else’s AOD use.
• For people who received treatment for their own AOD use:
• Over 2 in 5 (43%) treatment episodes were for alcohol, followed by amphetamines (24%), cannabis (17%) and heroin (4.5%).
• For clients, there was variation across age groups for the most common principal drugs of concern:
• Alcohol was the most common principal drug of concern for older clients (48% of those aged 40–49; 63% of those aged 50–59; and 77% of people aged 60 and over).
• Amphetamines were the most common principal drug of concern for clients aged in their 20s and 30s accounting for 1 in 3 clients aged 30‍–‍39 (32%) and 1 in 4 aged 20–29 (25%).
• Cannabis was the most common principal drug of concern for younger clients, with almost 2 in 3 (64%) clients aged 10–19 receiving treatment for cannabis.
• Counselling continues to be the most common treatment provided.
• 2 in 3 treatment episodes were provided in a non-residential treatment setting.